Home Nitro Compounds 152460-08-7
152460-08-7,MFCD09842424
Catalog No.:AA003BL0

152460-08-7 | 1-(2-Methyl-5-nitrophenyl)guanidine nitrate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
95%
in stock  
$9.00   $6.00
- +
25g
95%
in stock  
$24.00   $17.00
- +
100g
95%
in stock  
$83.00   $58.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003BL0
Chemical Name:
1-(2-Methyl-5-nitrophenyl)guanidine nitrate
CAS Number:
152460-08-7
Molecular Formula:
C8H9N5O5
Molecular Weight:
255.1876
MDL Number:
MFCD09842424
SMILES:
NC(=NO[N+](=O)[O-])Nc1cc(ccc1C)[N+](=O)[O-]
Properties
Properties
 
BP:
426.7°C at 760 mmHg  
Form:
Solid  
MP:
218-219 °C  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
269  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
1  

Downstream Synthesis Route
55314-16-4   
1-(2-methyl-5-nitrophenyl)guanidinenitrate 
  152460-09-8 

[1]Patent:WO2004/108699,2004,A1.Locationinpatent:Page17-40

[2]BioorganicandMedicinalChemistryLetters,1996,vol.6,p.1221-1226

[3]ArchivderPharmazie,1996,vol.329,p.371-376

[4]Patent:US5521184,1996,A

[5]Patent:US2004/224967,2004,A1

[6]Patent:WO2008/58037,2008,A1.Locationinpatent:Page/Pagecolumn29

[7]Patent:US2008/187575,2008,A1.Locationinpatent:Page/Pagecolumn27

[8]Patent:WO2004/99186,2004,A1.Locationinpatent:Page9;14

[9]Patent:WO2004/99187,2004,A1.Locationinpatent:Page8-9;13-14

[10]Patent:CN103739550,2016,B.Locationinpatent:Paragraph0181-0184

55314-16-4   
1-(2-methyl-5-nitrophenyl)guanidinenitrate 
  152460-09-8 

[1]Molecules,2009,vol.14,p.4166-4179

[2]DaltonTransactions,2014,vol.43,p.13299-13306

[3]EuropeanJournalofMedicinalChemistry,2011,vol.46,p.5817-5824

[4]Patent:US2008/300268,2008,A1.Locationinpatent:Page/Pagecolumn50

[5]JournalofMedicinalChemistry,2005,vol.48,p.249-255

[6]Patent:US2004/248918,2004,A1.Locationinpatent:Page6

[7]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.5232-5236

[8]BioorganicandMedicinalChemistry,2014,vol.22,p.623-632

[9]RSCAdvances,2016,vol.6,p.61458-61467

[10]Patent:WO2008/137794,2008,A1.Locationinpatent:Page/Pagecolumn26-27

[11]MedicinalChemistryResearch,2019,vol.28,p.633-645

420-04-2    99-55-8   
1-(2-methyl-5-nitrophenyl)guanidinenitrate 

[1]Locationinpatent:experimentalpartKoroleva;Ignatovich,Zh.V.;Ignatovich;Gusak[RussianJournalofOrganicChemistry,2011,vol.47,#8,p.1222-1226]

[2]CurrentPatentAssignee:HANGZHOUCANGHAIFANPHARMACEUTICALTECH-CN111039921,2020,ALocationinpatent:Paragraph0072-0077

[3]CurrentPatentAssignee:PHARMACEUTICALRESEARCHINSTITUTE-WO2006/71130,2006,A2Locationinpatent:Page/Pagecolumn22

[4]CurrentPatentAssignee:NATCOPHARMALIMITED-WO2004/108699,2004,A1Locationinpatent:Page16-39

[5]Locationinpatent:schemeortableKamal,Ahmed;Reddy,J.Surendranadha;Ramaiah,M.Janaki;Bharathi,E.Vijaya;Dastagiri;Reddy,M.Kashi;Pushpavalli;Pal-Bhadra,Manika[BioorganicandMedicinalChemistryLetters,2010,vol.20,#17,p.5232-5236]

[6]Locationinpatent:experimentalpartKamal,Ahmed;Dastagiri;JanakiRamaiah;SurendranadhaReddy;VijayaBharathi;KashiReddy;VictorPremSagar;LakshminarayanReddy;Pushpavalli;Pal-Bhadra,Manika[EuropeanJournalofMedicinalChemistry,2011,vol.46,#12,p.5817-5824]

[7]Moreno-Fuquen,Rodolfo;Arango-Daraviña,Kevin;Kennedy,AlanR.[ActaCrystallographicaSectionC:StructuralChemistry,2021,vol.77,p.621-632]

[8]Locationinpatent:experimentalpartChang,Sheng;Yin,Shi-Liang;Wang,Jian;Jing,Yong-Kui;Dong,Jin-Hua[Molecules,2009,vol.14,#10,p.4166-4179]

[9]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/300268,2008,A1Locationinpatent:Page/Pagecolumn50

[10]Szakács,Zoltán;Béni,Szabolcs;Varga,Zoltán;Örfi,László;Kéri,György;Noszál,Béla[JournalofMedicinalChemistry,2005,vol.48,#1,p.249-255]

[11]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US5521184,1996,A

[12]CurrentPatentAssignee:Chen,GuoqingP.-US2004/224967,2004,A1

[13]CurrentPatentAssignee:NOVARTISAG;IRMLLC;Novartis(w/oSandoz)-WO2008/58037,2008,A1Locationinpatent:Page/Pagecolumn29

[14]CurrentPatentAssignee:THEUNIVERSITYOFTEXASSYSTEM-WO2008/70350,2008,A2Locationinpatent:Page/Pagecolumn25;27;35

[15]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2009/93049,2009,A1Locationinpatent:Page/Pagecolumn34

[16]CurrentPatentAssignee:ILYANGPHARMCO.,LTD.-WO2004/99186,2004,A1Locationinpatent:Page9;14

[17]CurrentPatentAssignee:ILYANGPHARMCO.,LTD.-WO2004/99187,2004,A1Locationinpatent:Page8-9;13

[18]Peng,Zhenghong;Maxwell,DavidS.;Sun,Duoli;BhanuPrasad,BasvojuA.;Pal,Ashutosh;Wang,Shimei;Balatoni,Julius;Ghosh,Pradip;Lim,SeokT.;Volgin,Andrei;Shavrin,Aleksander;Alauddin,MianM.;Gelovani,JuriG.;Bornmann,WilliamG.[BioorganicandMedicinalChemistry,2014,vol.22,#1,p.623-632]

[19]Kinigopoulou;Filippidou;Gogou;Giannousi;Fouka;Ntemou;Alivertis;Georgis;Brentas;Polychronidou;Voulgari;Theodorou;Skobridis[RSCAdvances,2016,vol.6,#66,p.61458-61467]

[20]CurrentPatentAssignee:CHINAPHARMACEUTICALUNIVERSITY-CN103739550,2016,BLocationinpatent:Paragraph0181-0184

[21]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz);IRMLLC-WO2008/137794,2008,A1Locationinpatent:Page/Pagecolumn26-27

[22]Rahim,Abdul;Syed,Riyaz;Poornachandra;Malik,M.Shaheer;Reddy,Ch.VenkataRamana;Alvala,Mallika;Boppana,Kiran;Sridhar;Amanchy,Ramars;Kamal,Ahmed[MedicinalChemistryResearch,2019,vol.28,#5,p.633-645]

[1]Szakács,Zoltán;Béni,Szabolcs;Varga,Zoltán;Örfi,László;Kéri,György;Noszál,Béla[JournalofMedicinalChemistry,2005,vol.48,#1,p.249-255]

[2]Zimmermann,Juerg;Buchdunger,Elisabeth;Mett,Helmut;Meyer,Thomas;Lydon,NicholasB.;Traxler,Peter[BioorganicandMedicinalChemistryLetters,1996,vol.6,#11,p.1221-1226]

[3]Zimmermann,Juerg;Caravatti,Giorgio;Mett,Helmut;Meyer,Thomas;Mueller,Marcel;Lydon,NicholasB.;Fabbro,Doriano[ArchivderPharmazie,1996,vol.329,#7,p.371-376]

[4]Kamal,Ahmed;Dastagiri;JanakiRamaiah;SurendranadhaReddy;VijayaBharathi;KashiReddy;VictorPremSagar;LakshminarayanReddy;Pushpavalli;Pal-Bhadra,Manika[EuropeanJournalofMedicinalChemistry,2011,vol.46,#12,p.5817-5824]

[5]Peng,Zhenghong;Maxwell,DavidS.;Sun,Duoli;BhanuPrasad,BasvojuA.;Pal,Ashutosh;Wang,Shimei;Balatoni,Julius;Ghosh,Pradip;Lim,SeokT.;Volgin,Andrei;Shavrin,Aleksander;Alauddin,MianM.;Gelovani,JuriG.;Bornmann,WilliamG.[BioorganicandMedicinalChemistry,2014,vol.22,#1,p.623-632]

[6]Kinigopoulou;Filippidou;Gogou;Giannousi;Fouka;Ntemou;Alivertis;Georgis;Brentas;Polychronidou;Voulgari;Theodorou;Skobridis[RSCAdvances,2016,vol.6,#66,p.61458-61467]

[7]CurrentPatentAssignee:CHINAPHARMACEUTICALUNIVERSITY-CN103739550,2016,B

[8]CurrentPatentAssignee:Novartis(w/oSandoz);IRMLLC;NOVARTISAG-WO2008/137794,2008,A1

[9]Rahim,Abdul;Syed,Riyaz;Poornachandra;Malik,M.Shaheer;Reddy,Ch.VenkataRamana;Alvala,Mallika;Boppana,Kiran;Sridhar;Amanchy,Ramars;Kamal,Ahmed[MedicinalChemistryResearch,2019,vol.28,#5,p.633-645]

[10]CurrentPatentAssignee:HANGZHOUCANGHAIFANPHARMACEUTICALTECH-CN111039921,2020,A

1-(2-methyl-5-nitrophenyl)guanidinenitrate 
  152459-95-5 

[1]Szakács,Zoltán;Béni,Szabolcs;Varga,Zoltán;Örfi,László;Kéri,György;Noszál,Béla[JournalofMedicinalChemistry,2005,vol.48,#1,p.249-255]

[2]Peng,Zhenghong;Maxwell,DavidS.;Sun,Duoli;BhanuPrasad,BasvojuA.;Pal,Ashutosh;Wang,Shimei;Balatoni,Julius;Ghosh,Pradip;Lim,SeokT.;Volgin,Andrei;Shavrin,Aleksander;Alauddin,MianM.;Gelovani,JuriG.;Bornmann,WilliamG.[BioorganicandMedicinalChemistry,2014,vol.22,#1,p.623-632]

[3]Kinigopoulou;Filippidou;Gogou;Giannousi;Fouka;Ntemou;Alivertis;Georgis;Brentas;Polychronidou;Voulgari;Theodorou;Skobridis[RSCAdvances,2016,vol.6,#66,p.61458-61467]

[4]CurrentPatentAssignee:HANGZHOUCANGHAIFANPHARMACEUTICALTECH-CN111039921,2020,A

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 152460-08-7
Tags:152460-08-7 Molecular Formula|152460-08-7 MDL|152460-08-7 SMILES|152460-08-7 1-(2-Methyl-5-nitrophenyl)guanidine nitrate |Organic_Building_Blocks